ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Bioqual Inc (PK)

Bioqual Inc (PK) (BIOQ)

72.50
0.00
(0.00%)
Closed 24 June 6:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
72.50
Bid
70.00
Offer
79.00
Volume
-
0.00 Day's Range 0.00
59.00 52 Week Range 80.00
Market Cap
Previous Close
72.50
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
499
Shares Outstanding
894,416
Dividend Yield
0.69%
PE Ratio
77.66
Earnings Per Share (EPS)
0.93
Revenue
62.66M
Net Profit
835k

About Bioqual Inc (PK)

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Bioqual Inc (PK) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker BIOQ. The last closing price for Bioqual (PK) was US$72.50. Over the last year, Bioqual (PK) shares have traded in a share price range of US$ 59.00 to US$ 80.00.

Bioqual (PK) currently has 894,416 shares in issue. The market capitalisation of Bioqual (PK) is US$64.85 million. Bioqual (PK) has a price to earnings ratio (PE ratio) of 77.66.

BIOQ Latest News

No news to show yet.
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40072.572.572.592872.5CS
12-4.5-5.84415584416777772.549973.29659319CS
26-5.5-7.0512820512878807038674.04010657CS
520.50.69444444444472805953468.55613009CS
156-8.6-10.604192355181.1108.55751278.34433739CS
26036.75102.79720279735.75108.52859863.42466676CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TD1Tali Digital Limited
AUD 0.002
(100.00%)
250k
ENREncounter Resources Limited
AUD 0.615
(92.19%)
16.92M
ICRIntelicare Holdings Limited
AUD 0.014
(55.56%)
5.85M
CMOOCosmo Metals Ltd
AUD 0.02
(53.85%)
300k
SVGOSavannah Goldfields Ltd
AUD 0.003
(50.00%)
100k
CVVOBCaravel Minerals Limited
AUD 0.01
(-80.00%)
55.27k
BPMOBPM Minerals Limited
AUD 0.002
(-77.78%)
14.1k
CCXCity Chic Collective Limited
AUD 0.125
(-58.33%)
27.5M
KFMOKingfisher Mining Limited
AUD 0.001
(-50.00%)
254.82k
NTIOANeurotech International Limited
AUD 0.007
(-50.00%)
500k
CLZClassic Minerals Limited
AUD 0.0015
(-25.00%)
123.53M
MRQMRG Metals Ltd
AUD 0.0035
(0.00%)
80.19M
IMUImugene Limited
AUD 0.0555
(-4.31%)
44.29M
PENPeninsula Energy Ltd
AUD 0.10
(0.00%)
40.62M
AMDArrow Minerals Limited
AUD 0.0025
(-16.67%)
33.05M

BIOQ Discussion

View Posts
AskMuncher AskMuncher 4 years ago
$BIOQ BIOQUAL Presents Financial Results for Fiscal Year 2020 and Declares Dividend
Press Release | 09/15/2020
BIOQUAL ((OTC Pink: BIOQ) (www.bioqual.com):



2020




2019




Revenue

$

46,360,201


$

39,478,079




Income Before Income Tax

$

5,488,938


$

3,709,246




Net Income

$

4,230,938


$

2,830,875




Basic Earnings per Share








of Common Stock

$

4.74


$

3.17


Diluted Earnings per Share








of Common Stock

$

4.73


$

3.17


Weighted Average








Number of Shares Outstanding






For Basic Per Share



893,416




893,416


Weighted Average








Number of Shares Outstanding






For Diluted Earnings Per Share



893,971




893,655

BIOQUAL’s Board of Directors has declared a dividend of $1.10 per share for shareholders of record on September 28, 2020, payable on October 21, 2020. This is the nineteenth dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.


View source version on businesswire.com: https://www.businesswire.com/news/home/20200915005969/en/
👍️0
Ubertino Ubertino 9 years ago
Get on a decent exchange!

Too easily to manipulate as an OTC-Pinky!

Get on a decent exchange - NYSE or affiliate - then I might be interested.
👍️0

Your Recent History

Delayed Upgrade Clock